Orange Book product · Brand (NDA)
HEMABATE
CARBOPROST TROMETHAMINE
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
AP
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
CARBOPROST TROMETHAMINE
Strength
EQ 0.25MG BASE/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
NDA 017989
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2026CARBOPROST TROMETHAMINEGeneric (ANDA)
ANDA 219529 · SOMERSET THERAPS LLC
- 2024CARBOPROST TROMETHAMINEGeneric (ANDA)
ANDA 218013 · MICRO LABS
- 2024CARBOPROST TROMETHAMINEGeneric (ANDA)
ANDA 215901 · ANI PHARMS
- 2023CARBOPROST TROMETHAMINEGeneric (ANDA)
ANDA 217657 · GLAND
- 2023CARBOPROST TROMETHAMINEGeneric (ANDA)
ANDA 216897 · ONESOURCE SPECIALTY
- 2023CARBOPROST TROMETHAMINEGeneric (ANDA)
ANDA 217198 · ALEMBIC
- 2023CARBOPROST TROMETHAMINEGeneric (ANDA)
ANDA 216939 · EUGIA PHARMA
- 2023CARBOPROST TROMETHAMINEGeneric (ANDA)
ANDA 216824 · SOLA PHARMS
- 2023CARBOPROST TROMETHAMINEGeneric (ANDA)
ANDA 216882 · CAPLIN
- 2022CARBOPROST TROMETHAMINEGeneric (ANDA)
ANDA 214499 · LONG GROVE PHARMS
- 2022CARBOPROST TROMETHAMINEGeneric (ANDA)
ANDA 215337 · AMNEAL
- 2021CARBOPROST TROMETHAMINEGeneric (ANDA)
ANDA 213118 · SUNNY
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
